Journal of Medical Physics
 Home | Search | Ahead of print | Current Issue | Archives | Instructions | Subscription | Login  The official journal of AMPI, IOMP and AFOMP      
 Users online: 386  Home  EMail this page Print this page Decrease font size Default font size Increase font size 
Year : 2016  |  Volume : 41  |  Issue : 3  |  Page : 162-168

Dosimetric and radiobiological characterizations of prostate intensity-modulated radiotherapy and volumetric-modulated arc therapy: A single-institution review of ninety cases

1 Department of Physics, University of Gujrat, Gujrat, India
2 Department of Medical Physics, Grand River Regional Cancer Centre, Kitchener; Department of Physics and Astronomy, University of Waterloo, Waterloo, Canada
3 Department of Physics and Astronomy, University of Waterloo, Waterloo, Canada
4 Department of Physics, BUITEMS, Quetta, Pakistan
5 Department of Physics, Islamia University of Bahawalpur, Bahawalpur, Pakistan
6 Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network; Department of Radiation Oncology, University of Toronto, Toronto, Canada

Correspondence Address:
James C.L. Chow
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0971-6203.189479

Rights and Permissions

This study reviewed prostate volumetric-modulated arc therapy (VMAT) plans with intensity-modulated radiotherapy (IMRT) plans after prostate IMRT technique was replaced by VMAT in an institution. Characterizations of dosimetry and radiobiological variation in prostate were determined based on treatment plans of 40 prostate IMRT patients (planning target volume = 77.8-335 cm 3 ) and 50 VMAT patients (planning target volume = 120-351 cm 3 ) treated before and after 2013, respectively. Both IMRT and VMAT plans used the same dose-volume criteria in the inverse planning optimization. Dose-volume histogram, mean doses of target and normal tissues (rectum, bladder and femoral heads), dose-volume points (D 99% of planning target volume; D 30% , D 50% , V 30 Gy and V 35 Gy of rectum and bladder; D 5% , V 14 Gy , V 22 Gy of femoral heads), conformity index (CI), homogeneity index (HI), gradient index (GI), prostate tumor control probability (TCP), and rectal normal tissue complication probability (NTCP) based on the Lyman-Burman-Kutcher algorithm were calculated for each IMRT and VMAT plan. From our results, VMAT plan was found better due to its higher (1.05%) CI, lower (0.83%) HI and (0.75%) GI than IMRT. Comparing doses in normal tissues between IMRT and VMAT, it was found that IMRT mostly delivered higher doses of about 1.05% to the normal tissues than VMAT. Prostate TCP and rectal NTCP were found increased (1%) for VMAT than IMRT. It is seen that VMAT technique can decrease the dose-volume evaluation criteria for the normal tissues. Based on our dosimetric and radiobiological results in treatment plans, it is concluded that our VMAT implementation could produce comparable or slightly better target coverage and normal tissue sparing with a faster treatment time in prostate radiotherapy.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded251    
    Comments [Add]    
    Cited by others 8    

Recommend this journal